Enfusion Inc (ENFN)

$10.23

+0.25

(+2.51%)▲

Market is closed - opens 8 PM, 01 Dec 2023

Insights on Enfusion Inc

  • Increasing Revenue

    Revenue is up for the last 13 quarters, 19.78M → 44.35M (in $), with an average increase of 6.5% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 629.0K → 1.82M (in $), with an average increase of 65.6% per quarter

  • Vs UBER

    In the last 1 year, Uber Technologies, Inc. has given 93.5% return, outperforming this stock by 89.0%

Performance

  • $9.98
    $10.24
    $10.23
    downward going graph

    2.44%

    Downside

    Day's Volatility :2.54%

    Upside

    0.1%

    downward going graph
  • $7.37
    $12.32
    $10.23
    downward going graph

    27.96%

    Downside

    52 Weeks Volatility :40.18%

    Upside

    16.96%

    downward going graph

Returns

PeriodEnfusion IncSector (Technology)Index (Russel 2000)
3 Months
16.05%
5.8%
0.0%
6 Months
29.11%
11.6%
0.0%
1 Year
4.5%
36.0%
-6.2%
3 Years
-49.62%
49.7%
-2.8%

Highlights

Market Capitalization
873.1M
Book Value
$0.57
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
0.07
PE Ratio
141.29
Wall Street Target Price
9.96
Profit Margin
3.5%
Operating Margin TTM
6.06%
Return On Assets TTM
6.43%
Return On Equity TTM
10.36%
Revenue TTM
168.6M
Revenue Per Share TTM
1.91
Quarterly Revenue Growth YOY
13.3%
Gross Profit TTM
103.2M
EBITDA
16.2M
Diluted Eps TTM
0.07
Quarterly Earnings Growth YOY
0.06
EPS Estimate Current Year
0.15
EPS Estimate Next Year
0.25
EPS Estimate Current Quarter
0.05
EPS Estimate Next Quarter
0.06

Analyst Recommendation

Buy
    61%Buy
    30%Hold
    7%Sell
Based on 13 Wall street analysts offering stock ratings for Enfusion Inc(by analysts ranked 0 to 5 stars)
Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
4
4
5
Sell
1
1
1

Analyst Forecast

What analysts predicted

Downside of 2.64%

Current $10.23
Target $9.96

Company Financials

FY19Y/Y Change
Revenue
59.0M
-
Net Income
12.7M
-
Net Profit Margin
21.44%
-
FY20Y/Y Change
Revenue
79.6M
↑ 34.79%
Net Income
4.1M
↓ 67.91%
Net Profit Margin
5.1%
↓ 16.34%
FY21Y/Y Change
Revenue
111.7M
↑ 40.39%
Net Income
-282.2M
↓ 7050.06%
Net Profit Margin
-252.68%
↓ 257.78%
FY22Y/Y Change
Revenue
150.3M
↑ 34.6%
Net Income
-13.3M
↓ 95.3%
Net Profit Margin
-8.82%
↑ 243.86%
Q2 FY22Q/Q Change
Revenue
36.5M
↑ 7.03%
Net Income
-4.1M
↓ 67.06%
Net Profit Margin
-11.29%
↑ 25.39%
Q3 FY22Q/Q Change
Revenue
39.2M
↑ 7.15%
Net Income
2.6M
↓ 162.98%
Net Profit Margin
6.64%
↑ 17.93%
Q4 FY22Q/Q Change
Revenue
40.5M
↑ 3.49%
Net Income
788.0K
↓ 69.67%
Net Profit Margin
1.94%
↓ 4.7%
Q1 FY23Q/Q Change
Revenue
41.0M
↑ 1.12%
Net Income
4.7M
↑ 495.69%
Net Profit Margin
11.46%
↑ 9.52%
Q2 FY23Q/Q Change
Revenue
42.7M
↑ 4.27%
Net Income
629.0K
↓ 86.6%
Net Profit Margin
1.47%
↓ 9.99%
Q3 FY23Q/Q Change
Revenue
44.4M
↑ 3.83%
Net Income
1.8M
↑ 190.62%
Net Profit Margin
4.12%
↑ 2.65%
FY19Y/Y Change
Total Assets
23.2M
-
Total Liabilities
141.1M
-
FY20Y/Y Change
Total Assets
39.1M
↑ 68.55%
Total Liabilities
272.7M
↑ 93.27%
FY21Y/Y Change
Total Assets
106.1M
↑ 171.32%
Total Liabilities
8.6M
↓ 96.83%
FY22Y/Y Change
Total Assets
123.8M
↑ 16.68%
Total Liabilities
20.3M
↑ 135.3%
Q2 FY22Q/Q Change
Total Assets
110.1M
↑ 4.93%
Total Liabilities
10.3M
↑ 25.21%
Q3 FY22Q/Q Change
Total Assets
115.6M
↑ 4.97%
Total Liabilities
12.4M
↑ 20.45%
Q4 FY22Q/Q Change
Total Assets
123.8M
↑ 7.08%
Total Liabilities
20.3M
↑ 63.6%
Q1 FY23Q/Q Change
Total Assets
121.5M
↓ 1.85%
Total Liabilities
22.3M
↑ 9.88%
Q2 FY23Q/Q Change
Total Assets
94.1M
↓ 22.59%
Total Liabilities
21.8M
↓ 2.41%
Q3 FY23Q/Q Change
Total Assets
101.7M
↑ 8.17%
Total Liabilities
28.5M
↑ 30.5%
FY19Y/Y Change
Operating Cash Flow
12.3M
-
Investing Cash Flow
-4.4M
-
Financing Cash Flow
-7.5M
-
FY20Y/Y Change
Operating Cash Flow
1.7M
↓ 86.47%
Investing Cash Flow
-5.1M
↑ 14.43%
Financing Cash Flow
11.6M
↓ 253.28%
FY21Y/Y Change
Operating Cash Flow
-318.0K
↓ 119.1%
Investing Cash Flow
-8.0M
↑ 58.13%
Financing Cash Flow
58.8M
↑ 409.12%
FY22Y/Y Change
Operating Cash Flow
14.2M
↓ 4551.57%
Investing Cash Flow
-7.9M
↓ 1.04%
Financing Cash Flow
-8.0M
↓ 113.52%
Q2 FY22Q/Q Change
Operating Cash Flow
2.9M
↓ 170.54%
Investing Cash Flow
-2.1M
↓ 34.03%
Financing Cash Flow
-92.0K
↓ 88.57%
Q3 FY22Q/Q Change
Operating Cash Flow
7.8M
↑ 171.35%
Investing Cash Flow
-922.0K
↓ 55.93%
Financing Cash Flow
-20.0K
↓ 78.26%
Q4 FY22Q/Q Change
Operating Cash Flow
7.5M
↓ 4.09%
Investing Cash Flow
-1.7M
↑ 89.37%
Financing Cash Flow
-7.0M
↑ 35110.0%
Q1 FY23Q/Q Change
Operating Cash Flow
924.0K
↓ 87.71%
Investing Cash Flow
-2.6M
↑ 46.05%
Financing Cash Flow
-6.4M
↓ 9.78%
Q2 FY23Q/Q Change
Operating Cash Flow
6.0M
↑ 551.3%
Investing Cash Flow
-2.2M
↓ 12.98%
Financing Cash Flow
-30.8M
↑ 385.47%

Technicals Summary

Sell

Neutral

Buy

Enfusion Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Enfusion Inc
Enfusion Inc
22.45%
29.11%
4.5%
-49.62%
-49.62%
Shopify Inc.
Shopify Inc.
56.29%
26.02%
79.38%
-32.75%
380.35%
Uber Technologies, Inc.
Uber Technologies, Inc.
31.99%
50.16%
93.55%
13.57%
35.67%
Servicenow, Inc.
Servicenow, Inc.
19.42%
23.64%
63.09%
27.01%
266.45%
Salesforce Inc
Salesforce Inc
15.6%
5.25%
43.74%
-6.29%
61.35%
Intuit Inc.
Intuit Inc.
18.41%
42.14%
41.62%
63.98%
169.07%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Enfusion Inc
Enfusion Inc
141.29
141.29
NA
0.15
0.1
0.06
0.0
0.57
Shopify Inc.
Shopify Inc.
647.2
NA
26.2
0.69
-0.14
-0.01
0.0
6.45
Uber Technologies, Inc.
Uber Technologies, Inc.
106.38
106.38
NA
0.33
0.12
0.01
0.0
4.67
Servicenow, Inc.
Servicenow, Inc.
86.95
86.95
1.52
10.46
0.27
0.03
0.0
35.11
Salesforce Inc
Salesforce Inc
141.12
141.12
1.36
4.93
0.03
0.03
0.0
59.57
Intuit Inc.
Intuit Inc.
66.65
66.65
1.91
14.23
0.14
0.07
0.01
61.58
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Enfusion Inc
Enfusion Inc
Buy
$873.1M
-49.62%
141.29
3.5%
Shopify Inc.
Shopify Inc.
Buy
$90.3B
380.35%
647.2
-17.27%
Uber Technologies, Inc.
Uber Technologies, Inc.
Buy
$113.8B
35.67%
106.38
2.93%
Servicenow, Inc.
Servicenow, Inc.
Buy
$138.2B
266.45%
86.95
18.72%
Salesforce Inc
Salesforce Inc
Buy
$218.3B
61.35%
141.12
4.77%
Intuit Inc.
Intuit Inc.
Buy
$157.1B
169.07%
66.65
16.59%

Institutional Holdings

  • ICONIQ Capital, LLC

    15.91%

  • Brown Capital Management, LLC

    12.57%

  • Hillhouse Capital Advisors, Ltd.

    5.64%

  • Vanguard Group Inc

    3.95%

  • Ararat Capital Management, LP

    2.68%

  • BlackRock Inc

    2.65%

Company Information

enfusion is the leading provider of a cloud-based portfolio management and risk system. headquartered in chicago, illinois, with a branch office in new york, new york, and wholly-owned subsidiaries in london and hong kong, enfusion is a software company that focuses on delivering innovative solutions for clients in the financial services industry. our clients across the globe rely on our innovative real-time performance, risk calculations and accounting for some of the most sophisticated financial products. enfusion is undergoing exceptional growth and currently serves some of the world's largest and respected hedge funds with over 90 billion dollars of assets under management.

Organization
Enfusion Inc
Employees
1006
CEO
Mr. Oleg Movchan
Industry
Technology

Discover More

FAQs